You have 9 free searches left this month | for more free features.

exudative AMD

Showing 1 - 25 of 875

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sinusitis inSingle-center Prospective Cohort of Exudative AMD

Recruiting
  • AMD
  • sinusitis screening consultation
  • Paris, France
    Hôpital Fondation A. de Rothschild
Jan 23, 2023

Exudative Age-Related Macular Degeneration Trial in Chongqing (different degrees of adjustment of the injection interval)

Enrolling by invitation
  • Exudative Age-Related Macular Degeneration
  • different degrees of adjustment of the injection interval
  • Chongqing, China
    The First Affiliated Hospital of Chongqing Medical University
Sep 10, 2022

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    Non Exudative AMD Imaged With SS-OCT

    Active, not recruiting
    • Dry Macular Degeneration
    • SS-OCT imaging
    • Los Angeles, California
    • +4 more
    Mar 8, 2022

    Non Exudative AMD Imaged With SS-OCT- Extension

    Recruiting
    • Dry Macular Degeneration
    • SS-OCT imaging
    • Los Angeles, California
    • +4 more
    Mar 8, 2022

    Following Intensive Anti-VEGF Therapy in Wet AMD

    Completed
    • Age-Related Macular Degeneration
    • Budapest, Hungary
    • +1 more
    Dec 28, 2022

    CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea

    Active, not recruiting
    • AMD
    • Exudative Macular Degeneration
      • Bordeaux, France
      • +4 more
      Dec 2, 2022

      Age Related Macular Degeneration Trial in Indianapolis (RBM-007 Injectable Solution)

      Recruiting
      • Age Related Macular Degeneration
      • RBM-007 Injectable Solution
      • Indianapolis, Indiana
        Midwest Eye Institute
      Feb 10, 2022

      Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)

      Recruiting
      • Exudative Macular Degeneration
      • Wet Age-related Macular Degeneration
      • Doxycycline Hyclate
      • Placebo
      • Iowa City, Iowa
        University of Iowa Hospitals & Clinics Department of Ophthalmolo
      Apr 5, 2022

      Exudative Macular Degeneration Trial in Vienna (anti-VEGF agent)

      Recruiting
      • Exudative Macular Degeneration
      • anti-VEGF agent
      • Vienna, Austria
        Department of Ophthalmology, Medical University of Vienna, Austr
      Oct 13, 2021

      AMD, Age-related Macular Degeneration, Choroidal Neovascularisation Trial in Poitiers (Resvega, Trans-Resveratrol, )

      Terminated
      • AMD
      • +2 more
      • Resvega
      • +2 more
      • Poitiers, France
        CHU de Poitiers - Ophtalmology
      May 29, 2020

      Ocular, Vascular, and Genetic Findings in AMD Patients

      Recruiting
      • Age-Related Macular Degeneration
      • No intervention
      • Tel Aviv, Israel
        Tel Aviv Sourasky Medical Center
      Aug 23, 2023

      OCTA Versus Structural OCT(Optical Coherence Tomography) in

      Completed
      • Macular Degeneration Exudative Eye Left
      • Macular Degeneration Exudative Eye Right
      • Follow-up
      • Créteil, France
      • +2 more
      Jul 8, 2020

      Exudative Age-related Macular Degeneration Trial (intravitreal injection)

      Completed
      • Exudative Age-related Macular Degeneration
      • intravitreal injection
      • (no location specified)
      Apr 19, 2022

      Neovascular Age-elated Macular Degeneration (Wet AMD), Exudative Macular Degeneration Trial in United States (LFG316, Placebo)

      Completed
      • Neovascular Age-elated Macular Degeneration (Wet AMD)
      • Exudative Macular Degeneration
      • Tucson, Arizona
      • +6 more
      Dec 11, 2020

      Age Related Macular Degeneration Trial in Lyon (Blood samples)

      Recruiting
      • Age Related Macular Degeneration
      • Blood samples
      • Lyon, France
        Service d'ophtalmologie-HOSPICES CIVILS DE LYON - Hôpital de la
      Jun 9, 2022

      Age-related Macular Degeneration Trial in Baltimore (VMS diary booklet, Standard of Care)

      Terminated
      • Age-related Macular Degeneration
      • VMS diary booklet
      • Standard of Care
      • Baltimore, Maryland
        Johns Hopkins University Wilmer Eye Institute
      Aug 12, 2019

      Progression of Early Atrophic Lesions

      Not yet recruiting
      • Age-Related Macular Degeneration
      • No intervention
      • Salt Lake City, Utah
        University of Utah
      Jul 26, 2023

      Neovascular (Wet) Age-Related Macular Degeneration Trial in United States (4D-150 IVT, Aflibercept IVT)

      Recruiting
      • Neovascular (Wet) Age-Related Macular Degeneration
      • 4D-150 IVT
      • Aflibercept IVT
      • Oxnard, California
      • +9 more
      Jun 13, 2022

      Geographic Atrophy Associated With Age-Related Macular

      Recruiting
      • Age-Related Macular Degeneration
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jul 21, 2022

        A Collaborative Resource of Heidelberg Multimodal Imaging of

        Not yet recruiting
        • Age Related Macular Degeneration
        • +3 more
        • Collection of both retrospective and prospective data collection in 3 visits.
        • (no location specified)
        Jan 16, 2023

        Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2

        Recruiting
        • Eye Diseases
        • +2 more
        • Pars plana vitrectomy
        • +3 more
        • Chelmsford, Essex, United Kingdom
        • +13 more
        Aug 2, 2022

        Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

        Enrolling by invitation
        • Wet Age-related Macular Degeneration
        • Neovascular Age-related Macular Degeneration
        • ADVM-022
        • Bakersfield, California
        • +8 more
        Dec 23, 2021

        Geographic Atrophy Trial in Bellaire, Dallas (OCU410)

        Recruiting
        • Geographic Atrophy
        • OCU410
        • Bellaire, Texas
        • +1 more
        Aug 25, 2023

        Exudative Macular Degeneration, Retinal Hemorrhage Trial in United Kingdom (Ranibizumab, C3F8 Gas, tPA)

        Completed
        • Exudative Macular Degeneration
        • Retinal Hemorrhage
        • Maidstone, Kent, United Kingdom
        • +4 more
        Jul 10, 2020